Operator`s manual

1 of 16
Director Signature__________________________________ Date___________________
Clinical Laboratories
Point of Care
Testing
ACCU-CHEK INFORM II BLOOD GLUCOSE DETERMINATION
I. PURPOSE AND PRINCIPLE
The Accu-Chek Inform II meter is used for Quantitative determination of glucose in
whole blood specimens. The enzyme on the test strip, mutant variant of quinoprotein
glucose dehydrogenase converts the glucose in the blood sample to gluconolactone.
This reaction creates a harmless electrical current that the meter interprets as a glucose
concentration in mg/dL.
The system is calibrated with venous blood containing various glucose concentrations
and is calibrated to deliver plasma-like results. The reference values are obtained using
a validated test method. This test method is referenced to the hexokinase method and
is traceable to an NIST standard.
II. SCOPE
The Accu-Chek Inform II meter is used for monitoring blood glucose levels in hospitals,
ambulatory practices, and home care settings. It is used in both adult, pediatric, neonate
patient populations, however, it’s accuracy and precision in critically ill patients has not
been evaulated. The test is to be used for monitoring glucose levels and should not be
used for diagnosis.
III. PERSONNEL
Intended for use by clinical personnel who have received training and demonstrated
competency in this procedure. In the hospital setting, this includes Clinical Laboratory
Scientists, Registered Nurses, Nurse Practitioners, Physician Assistants, Physicians,
Respiratory Tech. In the ambulatory setting, this includes the aforementioned
personnel as well as Medical Assistants, Licensed Vocational Nurses and other
licensed Technologists.
IV. SPECIMEN REQUIREMENTS AND INTERFERENCES
A. Use capillary whole blood samples obtained from fingerstick. For children under
12 months of age, sample is obtained from heel stick. Fingerstick and heel stick
samples must be tested immediately. Do not use plasma, serum or Cord Blood
samples.
B. Wipe away the first drop of blood with gauze and use the second free-flowing
drop of blood from the fingerstick site for testing.
C. Venous, arterial or neonatal blood sample collected in lithium heparin are also
acceptable. Sample must be tested within 30 minutes of drawing to minimize the
effects of glycolysis.
Rev 1, Ver 2, 9/9/2013

Summary of content (17 pages)